Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.14000
Abstract: Few studies have examined the effects of glucagon‐like peptide‐1 receptor agonist switching, particularly in Japanese patients. Therefore, we aimed to investigate the effects of switching from liraglutide to semaglutide or dulaglutide on blood glucose, body… read more here.
Keywords: liraglutide semaglutide; switching liraglutide; dulaglutide patients; effects switching ... See more keywords